- Report
- July 2024
- 158 Pages
Global
From €4056EUR$4,250USD£3,398GBP
- Report
- October 2024
Global
From €3340EUR$3,500USD£2,799GBP
- Report
- April 2022
Japan, United States, ... Japan, United States, Europe, Global
From €2625EUR$2,750USD£2,199GBP
- Report
- December 2021
Global
From €4629EUR$4,850USD£3,878GBP
- Report
- November 2024
Japan, United States, ... Japan, United States, Europe, Global
From €4295EUR$4,500USD£3,598GBP
- Report
- August 2024
Japan, United States, ... Japan, United States, Europe
From €3340EUR$3,500USD£2,799GBP
- Report
- July 2024
- 260 Pages
Global
From €2534EUR$2,655USD£2,123GBP
The Legionella Test market is a subset of the Infectious Disease Testing market. It is focused on the detection of Legionella bacteria, which can cause Legionnaires' disease, a severe form of pneumonia. Legionella testing is typically done on water samples from cooling towers, hot tubs, and other water sources. The test is used to identify the presence of Legionella bacteria and to determine the concentration of the bacteria in the sample.
Legionella testing is typically done in a laboratory setting, using a variety of methods such as culture, PCR, and antigen testing. The results of the test are used to determine the risk of Legionnaires' disease and to inform decisions about water treatment and other preventive measures.
Companies in the Legionella Test market include Bio-Rad Laboratories, Neogen Corporation, Thermo Fisher Scientific, and Merck KGaA. Show Less Read more